ALIGOS THERAPEUTICS INC shareholders Q3 2023

ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 37 filers reported holding ALIGOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

ALIGOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 2,320,381$1,733,3250.92%
TANG CAPITAL MANAGEMENT LLC 3,329,048$2,486,7990.35%
Vivo Capital, LLC 3,547,030$2,649,6310.29%
Pivotal bioVenture Partners Investment Advisor LLC 743,215$555,1820.22%
Newtyn Management, LLC 920,000$687,2400.17%
SILVERARC CAPITAL MANAGEMENT, LLC 631,887$472,0200.14%
EcoR1 Capital, LLC 3,948,360$2,949,4250.10%
HHLR ADVISORS, LTD. 2,309,764$1,725,3940.04%
Baker Brothers Advisors 2,076,400$1,551,0710.01%
HARBOURVEST PARTNERS LLC 18,783$14,0310.01%
ACADIAN ASSET MANAGEMENT LLC 564,715$4200.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 92,000$68,7240.00%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,223,278$913,7890.00%
Choate Investment Advisors 24,000$17,9280.00%
BANK OF AMERICA CORP /DE/ 1,150,227$859,2200.00%
WELLS FARGO & COMPANY/MN 195$1460.00%
NORTHERN TRUST CORP 39,351$29,3950.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Qube Research & Technologies Ltd 2$10.00%
GEODE CAPITAL MANAGEMENT, LLC 241,503$180,4630.00%
External links

This page lists ALIGOS THERAPEUTICS INC's shareholders in Q3 2023. To view ALIGOS THERAPEUTICS INC's shareholder history, click here.